Get Premium to unlock powerful stock data

Redmile Group, LLC Buys Adagio Therapeutics Inc, Absci Corp, LivaNova PLC, Sells DexCom Inc, Zymergen Inc, SelectQuote Inc

Author's Avatar
insider
Nov 16, 2021
Article's Main Image
San Francisco, CA, based Investment company Redmile Group, LLC (Current Portfolio) buys Adagio Therapeutics Inc, Absci Corp, LivaNova PLC, SomaLogic Inc, Stevanato Group SPA, sells DexCom Inc, Zymergen Inc, SelectQuote Inc, Charles River Laboratories International Inc, Cigna Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Redmile Group, LLC. As of 2021Q3, Redmile Group, LLC owns 75 stocks with a total value of $5.7 billion. These are the details of the buys and sells.

For the details of Redmile Group, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/redmile+group%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Redmile Group, LLC
  1. Fate Therapeutics Inc (FATE) - 12,957,222 shares, 13.39% of the total portfolio.
  2. Allakos Inc (ALLK) - 2,131,796 shares, 3.94% of the total portfolio. Shares reduced by 3.84%
  3. IGM Biosciences Inc (IGMS) - 3,425,455 shares, 3.93% of the total portfolio.
  4. argenx SE (ARGX) - 730,582 shares, 3.85% of the total portfolio. Shares reduced by 7.55%
  5. ADC Therapeutics SA (ADCT) - 7,529,329 shares, 3.57% of the total portfolio. Shares added by 0.10%
New Purchase: Adagio Therapeutics Inc (ADGI)

Redmile Group, LLC initiated holding in Adagio Therapeutics Inc. The purchase prices were between $20.88 and $56.08, with an estimated average price of $37.24. The stock is now traded at around $20.200000. The impact to a portfolio due to this purchase was 2.39%. The holding were 3,246,960 shares as of 2021-09-30.

New Purchase: Absci Corp (ABSI)

Redmile Group, LLC initiated holding in Absci Corp. The purchase prices were between $10.37 and $30.29, with an estimated average price of $19.43. The stock is now traded at around $12.070000. The impact to a portfolio due to this purchase was 1.63%. The holding were 8,031,094 shares as of 2021-09-30.

New Purchase: SomaLogic Inc (SLGC)

Redmile Group, LLC initiated holding in SomaLogic Inc. The purchase prices were between $10.2 and $12.77, with an estimated average price of $11.41. The stock is now traded at around $13.720000. The impact to a portfolio due to this purchase was 0.86%. The holding were 3,972,270 shares as of 2021-09-30.

New Purchase: Stevanato Group SPA (STVN)

Redmile Group, LLC initiated holding in Stevanato Group SPA. The purchase prices were between $19.51 and $28.7, with an estimated average price of $23.62. The stock is now traded at around $22.050000. The impact to a portfolio due to this purchase was 0.52%. The holding were 1,187,025 shares as of 2021-09-30.

New Purchase: Zogenix Inc (ZGNX)

Redmile Group, LLC initiated holding in Zogenix Inc. The purchase prices were between $13.11 and $18.46, with an estimated average price of $15.64. The stock is now traded at around $14.410000. The impact to a portfolio due to this purchase was 0.27%. The holding were 1,014,414 shares as of 2021-09-30.

Added: LivaNova PLC (LIVN)

Redmile Group, LLC added to a holding in LivaNova PLC by 97.09%. The purchase prices were between $76.02 and $88.62, with an estimated average price of $82.24. The stock is now traded at around $86.010000. The impact to a portfolio due to this purchase was 1.49%. The holding were 2,191,019 shares as of 2021-09-30.

Added: UnitedHealth Group Inc (UNH)

Redmile Group, LLC added to a holding in UnitedHealth Group Inc by 27.78%. The purchase prices were between $390.74 and $429.71, with an estimated average price of $414.25. The stock is now traded at around $449.620000. The impact to a portfolio due to this purchase was 0.18%. The holding were 120,710 shares as of 2021-09-30.

Added: Gritstone Bio Inc (GRTS)

Redmile Group, LLC added to a holding in Gritstone Bio Inc by 26.72%. The purchase prices were between $6.41 and $13.54, with an estimated average price of $9.12. The stock is now traded at around $10.870000. The impact to a portfolio due to this purchase was 0.11%. The holding were 2,821,085 shares as of 2021-09-30.

Sold Out: DexCom Inc (DXCM)

Redmile Group, LLC sold out a holding in DexCom Inc. The sale prices were between $426.84 and $572.73, with an estimated average price of $503.9.

Sold Out: Zymergen Inc (ZY)

Redmile Group, LLC sold out a holding in Zymergen Inc. The sale prices were between $8.25 and $41, with an estimated average price of $21.41.

Sold Out: SelectQuote Inc (SLQT)

Redmile Group, LLC sold out a holding in SelectQuote Inc. The sale prices were between $7.89 and $19.75, with an estimated average price of $15.07.

Sold Out: Charles River Laboratories International Inc (CRL)

Redmile Group, LLC sold out a holding in Charles River Laboratories International Inc. The sale prices were between $372.64 and $458.3, with an estimated average price of $415.21.

Sold Out: Cigna Corp (CI)

Redmile Group, LLC sold out a holding in Cigna Corp. The sale prices were between $200.16 and $238.3, with an estimated average price of $217.75.

Sold Out: Catalent Inc (CTLT)

Redmile Group, LLC sold out a holding in Catalent Inc. The sale prices were between $109.17 and $142.35, with an estimated average price of $124.9.



Here is the complete portfolio of Redmile Group, LLC. Also check out:

1. Redmile Group, LLC's Undervalued Stocks
2. Redmile Group, LLC's Top Growth Companies, and
3. Redmile Group, LLC's High Yield stocks
4. Stocks that Redmile Group, LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus